POLYARTICULAR JUVENILE IDIOPATHIC ARTHRITIS
Clinical trials for POLYARTICULAR JUVENILE IDIOPATHIC ARTHRITIS explained in plain language.
Never miss a new study
Get alerted when new POLYARTICULAR JUVENILE IDIOPATHIC ARTHRITIS trials appear
Sign up with your email to follow new studies for POLYARTICULAR JUVENILE IDIOPATHIC ARTHRITIS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New combo therapy shows promise for kids with stubborn arthritis
Disease control CompletedThis study tested whether adding leflunomide to standard methotrexate treatment helps children with polyarticular juvenile idiopathic arthritis (JIA) that did not improve with methotrexate alone. Fifty children were randomly assigned to receive either the combination or methotrex…
Matched conditions: POLYARTICULAR JUVENILE IDIOPATHIC ARTHRITIS
Phase: PHASE4 • Sponsor: Bangladesh Medical University • Aim: Disease control
Last updated Jun 27, 2026 09:07 UTC
-
New IV drug shows promise for kids with stubborn arthritis
Disease control CompletedThis study tested an intravenous drug called golimumab in 130 children with active juvenile idiopathic arthritis that did not improve with methotrexate. The main goal was to measure how the drug moves through the body over time. The study was completed and provides information on…
Matched conditions: POLYARTICULAR JUVENILE IDIOPATHIC ARTHRITIS
Phase: PHASE3 • Sponsor: Janssen Research & Development, LLC • Aim: Disease control
Last updated Jun 27, 2026 07:57 UTC